UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

Diabetes (New York, N.Y.), 2000-04, Vol.49 (4), p.539-547

2000

Volltextzugriff (PDF)

SAT0244 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic dmards

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.984

2018

Volltextzugriff (PDF)

SAT0254 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from select-next

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.989

2018

Volltextzugriff (PDF)

PPAR gamma knockdown by engineered transcription factors: exogenous PPAR gamma 2 but not PPAR gamma 1 reactivates adipogenesis

Genes & development, 2002-01, Vol.16 (1), p.27-32

2002

Volltextzugriff (PDF)

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

The Journal of biological chemistry, 1997-04, Vol.272 (16), p.10811-10816

1997

Volltextzugriff (PDF)

Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors

The Journal of biological chemistry, 2001-10, Vol.276 (42), p.38341-38344

2001

Volltextzugriff (PDF)

A Novel Potent Antagonist of Peroxisome Proliferator-Activated Receptor γ Blocks Adipocyte Differentiation But Does Not Revert the Phenotype of Terminally Differentiated Adipocytes

Endocrinology (Philadelphia), 2001-07, Vol.142 (7), p.3207-3213

2001

Volltextzugriff (PDF)

Cloning, sequencing, and functional analysis of a Marek's disease virus origin of DNA replication

Journal of Virology, 1991-11, Vol.65 (11), p.6320-6324

1991

Volltextzugriff (PDF)

057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

2019

Volltextzugriff (PDF)

060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

Rheumatology (Oxford, England), 2019-04, Vol.58 (Supplement_3)

2019

Volltextzugriff (PDF)

Defective Marek's Disease Virus DNA Contains a Gene Encoding a Potential Nuclear DNA Binding Protein and a HSV a-like Sequence

Virology (New York, N.Y.), 1993-10, Vol.196 (2), p.484-495

1993

Volltextzugriff (PDF)

Adipogenesis and fat-cell function in obesity and diabetes

Trends in Molecular Medicine, 2002-09, Vol.8 (9), p.442-447

2002

Volltextzugriff (PDF)

THU0195 Preferential Inhibition of IL-6 Relative To IL-7 Signaling Pathways by ABT-494: Exposure-Response Analysis of ex-Vivo Data from Two Phase 1 Clinical Trials and Comparison To Tofacitinib

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.256-256

2016

Volltextzugriff (PDF)

AB0390 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance To Anti-TNF Biologic Therapy

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.1038-1039

2016

Volltextzugriff (PDF)

OP0223 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis with An Inadequate Response To Methotrexate

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.141-142

2016

Volltextzugriff (PDF)

Thiazolidinediones and Insulin Resistance: Peroxisome Proliferator-Activated Receptor γ Activation Stimulates Expression of the CAP Gene

Proceedings of the National Academy of Sciences - PNAS, 1998-12, Vol.95 (25), p.14751-14756

1998

Volltextzugriff (PDF)

Modulation of angiotensin II receptor (AT2) mRNA levels in R3T3 cells

Receptor, 1995, Vol.5 (2), p.123

1995

Volltextzugriff (PDF)

PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes

FEBS letters, 1999-03, Vol.447 (2-3), p.186-190

1999

Volltextzugriff (PDF)

c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity

Endocrinology (Philadelphia), 1999-01, Vol.140 (1), p.392-397

1999

Volltextzugriff (PDF)

PPARγ activators down-regulate the expression of PPARγ in 3T3-L1 adipocytes

FEBS letters, 1999-03, Vol.447 (2), p.186-190

1999

Volltextzugriff (PDF)

'I Could Not Stay There': Enslaved Women, Truancy and the Geography of Everyday Forms of Resistance in the Antebellum Plantation South

Slavery & abolition, 2002-12, Vol.23 (3), p.1-20

Camp, Stephanie M.H.

2002

Volltextzugriff (PDF)

Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor γ activation stimulates expression of the CAP gene

Proceedings of the National Academy of Sciences - PNAS, 1998-12, Vol.95 (25), p.14751-14756

1998

Volltextzugriff (PDF)

Review: peroxisome proliferator-activated receptor-gamma and its role in the development and treatment of diabetes

Experimental diabesity research, 2004-04, Vol.5 (2), p.99-109

2004

Volltextzugriff (PDF)

Abstract: Structural Styles of the Dezful Embayment, Zagros Mountains, Iran

AAPG bulletin, 2000, Vol.84 (2000)

Weldon H. Beauchamp1, David S. Camp

2000

Volltextzugriff (PDF)

A Botanical Trip in Delta and Ouray Counties, Colorado

The Asa Gray bulletin (1893), 1894-06, Vol.2 (5), p.19-21

CAMP, S. H.

1894

Volltextzugriff (PDF)

1 – 25 von 2.314

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.895)
Mit Volltextzugriff
(1.801)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.334)
Life Sciences & Biomedicine
(1.019)
Humans
(687)
Biological And Medical Sciences
(433)
Female
(366)
Male
(357)
Medical Sciences
(275)
Physical Sciences
(230)
Adult
(219)
Animals
(215)
Middle Aged
(206)
Fundamental And Applied Biological Sciences. Psychology
(193)
Technology
(133)
Aged
(128)
Microbiology
(127)
Genetics & Heredity
(126)
Biochemistry & Molecular Biology
(120)
Physics
(110)
Surgery
(95)
Mice
(88)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone

SAT0244 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic dmards

SAT0254 Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs: results from select-next

PPAR gamma knockdown by engineered transcription factors: exogenous PPAR gamma 2 but not PPAR gamma 1 reactivates adipogenesis

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

Regulation of transcription by AMP-activated protein kinase: phosphorylation of p300 blocks its interaction with nuclear receptors

A Novel Potent Antagonist of Peroxisome Proliferator-Activated Receptor γ Blocks Adipocyte Differentiation But Does Not Revert the Phenotype of Terminally Differentiated Adipocytes

Cloning, sequencing, and functional analysis of a Marek's disease virus origin of DNA replication

057 Impact of 12 weeks of upadacitinib treatment on individual and composite disease measures in patients with rheumatoid arthritis and inadequate response to conventional synthetic or biologic DMARDs

060 Upadacitinib as monotherapy: a phase 3 randomised controlled double-blind study in patients with active rheumatoid arthritis and inadequate response to methotrexate

Defective Marek's Disease Virus DNA Contains a Gene Encoding a Potential Nuclear DNA Binding Protein and a HSV a-like Sequence

Adipogenesis and fat-cell function in obesity and diabetes

THU0195 Preferential Inhibition of IL-6 Relative To IL-7 Signaling Pathways by ABT-494: Exposure-Response Analysis of ex-Vivo Data from Two Phase 1 Clinical Trials and Comparison To Tofacitinib

AB0390 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis and Inadequate Response or Intolerance To Anti-TNF Biologic Therapy

OP0223 Safety and Efficacy of ABT-494, A Novel Selective JAK1 Inhibitor, in Patients with Active Rheumatoid Arthritis with An Inadequate Response To Methotrexate

Thiazolidinediones and Insulin Resistance: Peroxisome Proliferator-Activated Receptor γ Activation Stimulates Expression of the CAP Gene

Modulation of angiotensin II receptor (AT2) mRNA levels in R3T3 cells

PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes

c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity

PPARγ activators down-regulate the expression of PPARγ in 3T3-L1 adipocytes

'I Could Not Stay There': Enslaved Women, Truancy and the Geography of Everyday Forms of Resistance in the Antebellum Plantation South

Thiazolidinediones and insulin resistance: Peroxisome proliferatoractivated receptor γ activation stimulates expression of the CAP gene

Review: peroxisome proliferator-activated receptor-gamma and its role in the development and treatment of diabetes

Abstract: Structural Styles of the Dezful Embayment, Zagros Mountains, Iran

A Botanical Trip in Delta and Ouray Counties, Colorado

Suchergebnisse filtern